AGER and atopic eczema: Wolf et al. also demonstrated that in vivo administration of RAGE-blocking antibodies ameliorated the clinical score of atopic dermatitis by reducing the levels of pro-inflammatory cytokines, even though the levels of IL-1α did not drop significantly [34].